Literature DB >> 7658918

Platelet-derived growth factor levels in wounds of diabetic rats.

D L Doxey1, M C Ng, R E Dill, A M Iacopino.   

Abstract

Delayed wound healing is a troublesome complication of Diabetes. Results from recent investigations concerning the potential cellular and molecular mechanisms responsible for diabetic wound healing deficiency are preliminary in nature. Some studies have demonstrated that direct application of certain growth factors/cytokines can facilitate wound healing in diabetic models. It is possible that refractory diabetic wounds are the result of deficiencies in growth factors/cytokines important for the normal wound healing process. Platelet-Derived Growth Factor (PDGF) levels were examined by radioimmunoassay in wound tissue of normal and diabetic rats (streptozotocin-induced diabetes). Immunohistochemical analysis was utilized to localize and characterize PDGF immunopositive cells at the wound site of normal and diabetic animals. At the wound site, normal animals demonstrated significantly elevated PDGF levels compared to diabetic animals at 5 days post-wounding (no differences were observed in the spleen or contralateral control tissue). There appeared to be a visible increase in PDGF immunopositive cells at the wound site in both experimental and control groups. By day 10 post-wounding, PDGF levels at the wound site in normal animals were reduced becoming similar to PDGF levels in diabetic animals. This corresponded to an apparent reduction of PDGF immunopositive cells in both groups (similar to baseline levels). PDGF levels in both groups remained stable until day 20 post-wounding when a significant elevation of wound site PDGF levels occurred in the diabetic group. The findings suggest that absence of an initial increase in PDGF may play an important role in poor wound healing observed in diabetic animals. The reduction in PDGF may be related to decreased cellular PDGF production rather than a lack of PDGF-producing cells. Perhaps the diabetic state inhibits cellular PDGF gene expression signaled by wounding or interferes with normal PDGF expression at the wound site.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7658918     DOI: 10.1016/0024-3205(95)02056-o

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  18 in total

Review 1.  A concomitant review of the effects of diabetes mellitus and hypothyroidism in wound healing.

Authors:  Konstantinos A Ekmektzoglou; Georgios C Zografos
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

2.  Decorin and suramin inhibit ocular fibroblast collagen production.

Authors:  H Mietz; P Chévez-Barrios; M W Lieberman; M Wendt; R Gross; S F Basinger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

Review 3.  Diabetic foot ulcers. Pathophysiology, assessment, and therapy.

Authors:  C K Bowering
Journal:  Can Fam Physician       Date:  2001-05       Impact factor: 3.275

4.  Antioxidant status in delayed healing type of wounds.

Authors:  A M Rasik; A Shukla
Journal:  Int J Exp Pathol       Date:  2000-08       Impact factor: 1.925

Review 5.  The mechanism of protracted wound healing on oral mucosa in diabetes. Review.

Authors:  Yoshihiro Abiko; Denis Selimovic
Journal:  Bosn J Basic Med Sci       Date:  2010-08       Impact factor: 3.363

6.  Synergistic effects of combined cytotoxic and apoptosis-inducing drugs on Tenon's capsule fibroblasts in vitro and in vivo.

Authors:  Holger Mietz; Gerhard Welsandt; Arno Hueber; Christina Esser; Günter K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02-21       Impact factor: 3.117

7.  Effects of octreotide acetate and amniotic membrane on wound healing in experimental glaucoma surgery.

Authors:  Tamer Demir; Burak Turgut; Ulku Celiker; Ibrahim Ozercan; Fatih Ulas; Nuray Akyol
Journal:  Doc Ophthalmol       Date:  2003-09       Impact factor: 2.379

8.  Suramin inhibits wound healing following filtering procedures for glaucoma.

Authors:  H Mietz; P Chévez-Barrios; R M Feldman; M W Lieberman
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

Review 9.  Epidermal growth factor in clinical practice - a review of its biological actions, clinical indications and safety implications.

Authors:  Jorge Berlanga-Acosta; Jorge Gavilondo-Cowley; Pedro López-Saura; Tania González-López; María D Castro-Santana; Ernesto López-Mola; Gerardo Guillén-Nieto; Luis Herrera-Martinez
Journal:  Int Wound J       Date:  2009-10       Impact factor: 3.315

10.  Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia.

Authors:  Oren Z Lerman; Robert D Galiano; Mary Armour; Jamie P Levine; Geoffrey C Gurtner
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.